Oncolytics Biotech (ONC) Competitors C$0.85 -0.05 (-5.56%) As of 03/28/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONC vs. ABCN, EMC, APS, FRX, BCT, IPA, SCYB, COM, NVH, and IGXShould you be buying Oncolytics Biotech stock or one of its competitors? The main competitors of Oncolytics Biotech include VIVO Cannabis (ABCN), Emblem (EMC), Aptose Biosciences (APS), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), and IntelGenx Technologies (IGX). These companies are all part of the "biotechnology" industry. Oncolytics Biotech vs. VIVO Cannabis Emblem Aptose Biosciences Fennec Pharmaceuticals BriaCell Therapeutics ImmunoPrecise Antibodies Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies VIVO Cannabis (CVE:ABCN) and Oncolytics Biotech (TSE:ONC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment, institutional ownership and community ranking. Is ABCN or ONC more profitable? VIVO Cannabis' return on equity of 0.00% beat Oncolytics Biotech's return on equity.Company Net Margins Return on Equity Return on Assets VIVO CannabisN/A N/A N/A Oncolytics Biotech N/A -141.94%-71.33% Does the MarketBeat Community favor ABCN or ONC? Oncolytics Biotech received 68 more outperform votes than VIVO Cannabis when rated by MarketBeat users. Likewise, 74.81% of users gave Oncolytics Biotech an outperform vote while only 71.91% of users gave VIVO Cannabis an outperform vote. CompanyUnderperformOutperformVIVO CannabisOutperform Votes12871.91% Underperform Votes5028.09% Oncolytics BiotechOutperform Votes19674.81% Underperform Votes6625.19% Do insiders & institutionals believe in ABCN or ONC? 1.8% of Oncolytics Biotech shares are owned by institutional investors. 3.8% of Oncolytics Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media refer more to ABCN or ONC? In the previous week, Oncolytics Biotech had 2 more articles in the media than VIVO Cannabis. MarketBeat recorded 2 mentions for Oncolytics Biotech and 0 mentions for VIVO Cannabis. VIVO Cannabis' average media sentiment score of 0.00 beat Oncolytics Biotech's score of -0.79 indicating that VIVO Cannabis is being referred to more favorably in the media. Company Overall Sentiment VIVO Cannabis Neutral Oncolytics Biotech Negative Which has better valuation and earnings, ABCN or ONC? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVIVO CannabisN/AN/AN/AN/AN/AOncolytics BiotechN/AN/A-C$27.66M-C$0.36-2.37 SummaryOncolytics Biotech beats VIVO Cannabis on 5 of the 8 factors compared between the two stocks. Remove Ads Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONC vs. The Competition Export to ExcelMetricOncolytics BiotechBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$65.51MC$110.43MC$5.63BC$5.65BDividend Yield0.31%3.78%5.33%6.44%P/E Ratio-2.373.1423.5829.77Price / SalesN/A4,278.81388.23616.16Price / Cash4.2212.7538.1783.35Price / Book7.2336.766.893.64Net Income-C$27.66M-C$91.48MC$3.20BC$300.33M7 Day Performance-6.59%-2.82%-3.06%-0.92%1 Month Performance-10.53%59.30%1.51%-0.22%1 Year Performance-41.38%85.98%9.37%14.71% Oncolytics Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOncolytics Biotech0.2556 of 5 starsC$0.85-5.6%C$3.50+311.8%-41.4%C$65.51MN/A-2.3729ABCNVIVO CannabisN/AC$1.32+5.6%N/A+0.0%C$256.62MN/A0.00N/AGap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AAPSAptose BiosciencesN/AC$5.41+3.6%N/A-92.8%C$232.95MN/A-1.0831News CoverageGap UpFRXFennec PharmaceuticalsN/AC$9.48+3.9%N/A-39.0%C$182.82MC$34.86M-160.5910BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap Up Remove Ads Related Companies and Tools Related Companies VIVO Cannabis Alternatives Emblem Alternatives Aptose Biosciences Alternatives Fennec Pharmaceuticals Alternatives BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:ONC) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredIs Trump Secretly Pumping Up Elon’s New AI Venture?President Trump just bought a Tesla - right in front of the White House. But what most investors don't real...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
